Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMSEKZG)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Proteinase activated receptor 2 (PAR2)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
MEDI0618	DM7GNSY	Osteoarthritis pain	MG30.31	Phase 1	[2]
Imidazopyridazine derivative 8	DMF7NXJ	Inflammation	1A00-CA43.1	Patented	[1]
Piperazine urea derivative 4	DM3K7IM	Inflammation	1A00-CA43.1	Patented	[1]
Piperidine derivative 2	DMHXMB4	Inflammation	1A00-CA43.1	Patented	[1]
Benzimidazole derivative 10	DML3PE4	N. A.	N. A.	Patented	[1]
Benzothiazine-carboxamide compound 2	DMMP2RT	Skin inflammation	EF20.Y	Patented	[1]
Amidine compound 3	DMV0QJ4	Inflammation	1A00-CA43.1	Patented	[1]
Benzothiazine-carboxamide compound 4	DMSR918	Skin inflammation	EF20.Y	Patented	[1]
Quinazoline derivative 11	DMAH435	Chronic obstructive pulmonary disease	CA22	Patented	[1]
PMID26936077-Compound-13	DMXK6LV	Gastric ulcer	DA60	Patented	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Proteinase activated receptor 2 (PAR2)	TTQR74A	PAR2_HUMAN	Agonist	[1]

------------------------------------------------------------------------------------

References

1	Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).Expert Opin Ther Pat. 2016;26(4):471-83.
2	Clinical pipeline report, company report or official report of AstraZeneca